April 21, 2022
NGM Bio to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., April 20, 2022 (GLOBE NEWSWIRE) — NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company…
Pharmaceuticals, Biotechnology and Life Sciences
SOUTH SAN FRANCISCO, Calif., April 20, 2022 (GLOBE NEWSWIRE) — NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company…
Company to host conference call following the presentationWARRINGTON, Pa., April 20, 2022 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT),…
MENLO PARK, Calif., April 20, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly…
The shareholders of Active Biotech AB (publ) are invited to the Annual General Meeting of shareholders to be held on…
Proceeds To Fund Research and Development of BWV-101, BWV-102 and BWV-103CINCINNATI, April 20, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines…
Live moderated video webcast with members of the Novan management team on Tuesday, April 26th at 2:00 PM ETDURHAM, N.C.,…
Athira Image 1 Athira Image 1 Athira Pharma 2 Athira Pharma 2 Urges shareholders to vote “FOR” Athira’s highly qualified,…
NGM831 and NGM438, NGM Bio’s myeloid reprogramming antibody product candidates targeting stromal checkpoints, will be showcased in the second of…
Data from studies evaluating ibrexafungerp in serious fungal infections will be presentedJERSEY CITY, N.J., April 20, 2022 (GLOBE NEWSWIRE) —…
CAMBRIDGE, Mass., April 20, 2022 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine…